{"id":637,"date":"2021-03-16T14:15:47","date_gmt":"2021-03-16T13:15:47","guid":{"rendered":"https:\/\/www.novacos-law.com\/de\/?p=637"},"modified":"2021-03-16T14:40:55","modified_gmt":"2021-03-16T13:40:55","slug":"24-marburger-gespraeche-zum-pharmarecht-18-und-19-maerz-2021-rechtliche-aspekte-von-performance-vertraegen-bei-der-zell-und-gentherapie","status":"publish","type":"post","link":"https:\/\/www.novacos-law.com\/de\/2021\/24-marburger-gespraeche-zum-pharmarecht-18-und-19-maerz-2021-rechtliche-aspekte-von-performance-vertraegen-bei-der-zell-und-gentherapie\/","title":{"rendered":"24. Marburger Gespr\u00e4che zum Pharmarecht (18. und 19. M\u00e4rz 2021) &#8211; Rechtliche Aspekte von Performance-Vertr\u00e4gen bei der Zell- und Gentherapie"},"content":{"rendered":"<p>Unser Partner Dr. Alexander Natz wird im Rahmen der 24. Marburger Gespr\u00e4che zum Pharmarecht am 18. M\u00e4rz 2021 online \u00fcber das Thema <strong>\u201eRechtliche Aspekte von Performance-Vertr\u00e4gen bei der Zell- und Gentherapie\u201c<\/strong> referieren.<\/p>\n<p>Weitere Informationen finden Sie\u00a0<a href=\"https:\/\/www.uni-marburg.de\/de\/fb01\/forschung\/forschungszentrum-und-projekte\/forschungsstellen\/pharmarecht\/veranstaltungen-weiterbildungen\/marburger-gespraeche-zum-pharmarecht\/24-marburger-gespraeche\">hier.<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Unser Partner Dr. Alexander Natz wird im Rahmen der 24. Marburger Gespr\u00e4che zum Pharmarecht am 18. M\u00e4rz 2021 online \u00fcber das Thema \u201eRechtliche Aspekte von Performance-Vertr\u00e4gen bei der Zell- und Gentherapie\u201c referieren. Weitere Informationen finden Sie\u00a0hier.<\/p>\n","protected":false},"author":8,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[7],"tags":[],"class_list":["post-637","post","type-post","status-publish","format-standard","hentry","category-events"],"acf":[],"aioseo_notices":[],"aioseo_head":"\n\t\t<!-- All in One SEO 4.9.9 - aioseo.com -->\n\t<meta name=\"description\" content=\"Unser Partner Dr. Alexander Natz wird im Rahmen der 24. Marburger Gespr\u00e4che zum Pharmarecht am 18. M\u00e4rz 2021 online \u00fcber das Thema \u201eRechtliche Aspekte von Performance-Vertr\u00e4gen bei der Zell- und Gentherapie\u201c referieren. Weitere Informationen finden Sie hier.\" \/>\n\t<meta name=\"robots\" content=\"max-image-preview:large\" \/>\n\t<meta name=\"author\" content=\"Irene Weigel\"\/>\n\t<link rel=\"canonical\" href=\"https:\/\/www.novacos-law.com\/de\/2021\/24-marburger-gespraeche-zum-pharmarecht-18-und-19-maerz-2021-rechtliche-aspekte-von-performance-vertraegen-bei-der-zell-und-gentherapie\/\" \/>\n\t<meta name=\"generator\" content=\"All in One SEO (AIOSEO) 4.9.9\" \/>\n\t\t<script type=\"application\/ld+json\" class=\"aioseo-schema\">\n\t\t\t{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.novacos-law.com\\\/de\\\/2021\\\/24-marburger-gespraeche-zum-pharmarecht-18-und-19-maerz-2021-rechtliche-aspekte-von-performance-vertraegen-bei-der-zell-und-gentherapie\\\/#article\",\"name\":\"24. Marburger Gespr\\u00e4che zum Pharmarecht (18. und 19. M\\u00e4rz 2021) \\u2013 Rechtliche Aspekte von Performance-Vertr\\u00e4gen bei der Zell- und Gentherapie | NOVACOS\",\"headline\":\"24. Marburger Gespr\\u00e4che zum Pharmarecht (18. und 19. M\\u00e4rz 2021) &#8211; Rechtliche Aspekte von Performance-Vertr\\u00e4gen bei der Zell- und Gentherapie\",\"author\":{\"@id\":\"https:\\\/\\\/www.novacos-law.com\\\/de\\\/author\\\/irene\\\/#author\"},\"publisher\":{\"@id\":\"https:\\\/\\\/www.novacos-law.com\\\/de\\\/#organization\"},\"datePublished\":\"2021-03-16T14:15:47+01:00\",\"dateModified\":\"2021-03-16T14:40:55+01:00\",\"inLanguage\":\"de-DE\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.novacos-law.com\\\/de\\\/2021\\\/24-marburger-gespraeche-zum-pharmarecht-18-und-19-maerz-2021-rechtliche-aspekte-von-performance-vertraegen-bei-der-zell-und-gentherapie\\\/#webpage\"},\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.novacos-law.com\\\/de\\\/2021\\\/24-marburger-gespraeche-zum-pharmarecht-18-und-19-maerz-2021-rechtliche-aspekte-von-performance-vertraegen-bei-der-zell-und-gentherapie\\\/#webpage\"},\"articleSection\":\"Events\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.novacos-law.com\\\/de\\\/2021\\\/24-marburger-gespraeche-zum-pharmarecht-18-und-19-maerz-2021-rechtliche-aspekte-von-performance-vertraegen-bei-der-zell-und-gentherapie\\\/#breadcrumblist\",\"itemListElement\":[{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.novacos-law.com\\\/de#listItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.novacos-law.com\\\/de\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.novacos-law.com\\\/de\\\/category\\\/events\\\/#listItem\",\"name\":\"Events\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.novacos-law.com\\\/de\\\/category\\\/events\\\/#listItem\",\"position\":2,\"name\":\"Events\",\"item\":\"https:\\\/\\\/www.novacos-law.com\\\/de\\\/category\\\/events\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.novacos-law.com\\\/de\\\/2021\\\/24-marburger-gespraeche-zum-pharmarecht-18-und-19-maerz-2021-rechtliche-aspekte-von-performance-vertraegen-bei-der-zell-und-gentherapie\\\/#listItem\",\"name\":\"24. Marburger Gespr\\u00e4che zum Pharmarecht (18. und 19. M\\u00e4rz 2021) &#8211; Rechtliche Aspekte von Performance-Vertr\\u00e4gen bei der Zell- und Gentherapie\"},\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.novacos-law.com\\\/de#listItem\",\"name\":\"Home\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.novacos-law.com\\\/de\\\/2021\\\/24-marburger-gespraeche-zum-pharmarecht-18-und-19-maerz-2021-rechtliche-aspekte-von-performance-vertraegen-bei-der-zell-und-gentherapie\\\/#listItem\",\"position\":3,\"name\":\"24. Marburger Gespr\\u00e4che zum Pharmarecht (18. und 19. M\\u00e4rz 2021) &#8211; Rechtliche Aspekte von Performance-Vertr\\u00e4gen bei der Zell- und Gentherapie\",\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.novacos-law.com\\\/de\\\/category\\\/events\\\/#listItem\",\"name\":\"Events\"}}]},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.novacos-law.com\\\/de\\\/#organization\",\"name\":\"Novacos Law\",\"description\":\"Heil \\u2022 H\\u00fcbner \\u2022 Natz \\u2022 Oeben Partnerschaft mbB\",\"url\":\"https:\\\/\\\/www.novacos-law.com\\\/de\\\/\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.novacos-law.com\\\/de\\\/author\\\/irene\\\/#author\",\"url\":\"https:\\\/\\\/www.novacos-law.com\\\/de\\\/author\\\/irene\\\/\",\"name\":\"Irene Weigel\",\"image\":{\"@type\":\"ImageObject\",\"@id\":\"https:\\\/\\\/www.novacos-law.com\\\/de\\\/2021\\\/24-marburger-gespraeche-zum-pharmarecht-18-und-19-maerz-2021-rechtliche-aspekte-von-performance-vertraegen-bei-der-zell-und-gentherapie\\\/#authorImage\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/4b6e23b267feeae9cffc7e4f81dbd2efa7e19c1035301edf6a24a7beb9ae5ac9?s=96&d=mm&r=g\",\"width\":96,\"height\":96,\"caption\":\"Irene Weigel\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.novacos-law.com\\\/de\\\/2021\\\/24-marburger-gespraeche-zum-pharmarecht-18-und-19-maerz-2021-rechtliche-aspekte-von-performance-vertraegen-bei-der-zell-und-gentherapie\\\/#webpage\",\"url\":\"https:\\\/\\\/www.novacos-law.com\\\/de\\\/2021\\\/24-marburger-gespraeche-zum-pharmarecht-18-und-19-maerz-2021-rechtliche-aspekte-von-performance-vertraegen-bei-der-zell-und-gentherapie\\\/\",\"name\":\"24. Marburger Gespr\\u00e4che zum Pharmarecht (18. und 19. M\\u00e4rz 2021) \\u2013 Rechtliche Aspekte von Performance-Vertr\\u00e4gen bei der Zell- und Gentherapie | NOVACOS\",\"description\":\"Unser Partner Dr. Alexander Natz wird im Rahmen der 24. Marburger Gespr\\u00e4che zum Pharmarecht am 18. M\\u00e4rz 2021 online \\u00fcber das Thema \\u201eRechtliche Aspekte von Performance-Vertr\\u00e4gen bei der Zell- und Gentherapie\\u201c referieren. Weitere Informationen finden Sie hier.\",\"inLanguage\":\"de-DE\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.novacos-law.com\\\/de\\\/#website\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.novacos-law.com\\\/de\\\/2021\\\/24-marburger-gespraeche-zum-pharmarecht-18-und-19-maerz-2021-rechtliche-aspekte-von-performance-vertraegen-bei-der-zell-und-gentherapie\\\/#breadcrumblist\"},\"author\":{\"@id\":\"https:\\\/\\\/www.novacos-law.com\\\/de\\\/author\\\/irene\\\/#author\"},\"creator\":{\"@id\":\"https:\\\/\\\/www.novacos-law.com\\\/de\\\/author\\\/irene\\\/#author\"},\"datePublished\":\"2021-03-16T14:15:47+01:00\",\"dateModified\":\"2021-03-16T14:40:55+01:00\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.novacos-law.com\\\/de\\\/#website\",\"url\":\"https:\\\/\\\/www.novacos-law.com\\\/de\\\/\",\"name\":\"Novacos Law\",\"description\":\"Heil \\u2022 H\\u00fcbner \\u2022 Natz \\u2022 Oeben Partnerschaft mbB\",\"inLanguage\":\"de-DE\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.novacos-law.com\\\/de\\\/#organization\"}}]}\n\t\t<\/script>\n\t\t<!-- All in One SEO -->\n\n","aioseo_head_json":{"title":"24. Marburger Gespr\u00e4che zum Pharmarecht (18. und 19. M\u00e4rz 2021) \u2013 Rechtliche Aspekte von Performance-Vertr\u00e4gen bei der Zell- und Gentherapie | NOVACOS","description":"Unser Partner Dr. Alexander Natz wird im Rahmen der 24. Marburger Gespr\u00e4che zum Pharmarecht am 18. M\u00e4rz 2021 online \u00fcber das Thema \u201eRechtliche Aspekte von Performance-Vertr\u00e4gen bei der Zell- und Gentherapie\u201c referieren. Weitere Informationen finden Sie hier.","canonical_url":"https:\/\/www.novacos-law.com\/de\/2021\/24-marburger-gespraeche-zum-pharmarecht-18-und-19-maerz-2021-rechtliche-aspekte-von-performance-vertraegen-bei-der-zell-und-gentherapie\/","robots":"max-image-preview:large","keywords":"","webmasterTools":{"miscellaneous":""},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.novacos-law.com\/de\/2021\/24-marburger-gespraeche-zum-pharmarecht-18-und-19-maerz-2021-rechtliche-aspekte-von-performance-vertraegen-bei-der-zell-und-gentherapie\/#article","name":"24. Marburger Gespr\u00e4che zum Pharmarecht (18. und 19. M\u00e4rz 2021) \u2013 Rechtliche Aspekte von Performance-Vertr\u00e4gen bei der Zell- und Gentherapie | NOVACOS","headline":"24. Marburger Gespr\u00e4che zum Pharmarecht (18. und 19. M\u00e4rz 2021) &#8211; Rechtliche Aspekte von Performance-Vertr\u00e4gen bei der Zell- und Gentherapie","author":{"@id":"https:\/\/www.novacos-law.com\/de\/author\/irene\/#author"},"publisher":{"@id":"https:\/\/www.novacos-law.com\/de\/#organization"},"datePublished":"2021-03-16T14:15:47+01:00","dateModified":"2021-03-16T14:40:55+01:00","inLanguage":"de-DE","mainEntityOfPage":{"@id":"https:\/\/www.novacos-law.com\/de\/2021\/24-marburger-gespraeche-zum-pharmarecht-18-und-19-maerz-2021-rechtliche-aspekte-von-performance-vertraegen-bei-der-zell-und-gentherapie\/#webpage"},"isPartOf":{"@id":"https:\/\/www.novacos-law.com\/de\/2021\/24-marburger-gespraeche-zum-pharmarecht-18-und-19-maerz-2021-rechtliche-aspekte-von-performance-vertraegen-bei-der-zell-und-gentherapie\/#webpage"},"articleSection":"Events"},{"@type":"BreadcrumbList","@id":"https:\/\/www.novacos-law.com\/de\/2021\/24-marburger-gespraeche-zum-pharmarecht-18-und-19-maerz-2021-rechtliche-aspekte-von-performance-vertraegen-bei-der-zell-und-gentherapie\/#breadcrumblist","itemListElement":[{"@type":"ListItem","@id":"https:\/\/www.novacos-law.com\/de#listItem","position":1,"name":"Home","item":"https:\/\/www.novacos-law.com\/de","nextItem":{"@type":"ListItem","@id":"https:\/\/www.novacos-law.com\/de\/category\/events\/#listItem","name":"Events"}},{"@type":"ListItem","@id":"https:\/\/www.novacos-law.com\/de\/category\/events\/#listItem","position":2,"name":"Events","item":"https:\/\/www.novacos-law.com\/de\/category\/events\/","nextItem":{"@type":"ListItem","@id":"https:\/\/www.novacos-law.com\/de\/2021\/24-marburger-gespraeche-zum-pharmarecht-18-und-19-maerz-2021-rechtliche-aspekte-von-performance-vertraegen-bei-der-zell-und-gentherapie\/#listItem","name":"24. Marburger Gespr\u00e4che zum Pharmarecht (18. und 19. M\u00e4rz 2021) &#8211; Rechtliche Aspekte von Performance-Vertr\u00e4gen bei der Zell- und Gentherapie"},"previousItem":{"@type":"ListItem","@id":"https:\/\/www.novacos-law.com\/de#listItem","name":"Home"}},{"@type":"ListItem","@id":"https:\/\/www.novacos-law.com\/de\/2021\/24-marburger-gespraeche-zum-pharmarecht-18-und-19-maerz-2021-rechtliche-aspekte-von-performance-vertraegen-bei-der-zell-und-gentherapie\/#listItem","position":3,"name":"24. Marburger Gespr\u00e4che zum Pharmarecht (18. und 19. M\u00e4rz 2021) &#8211; Rechtliche Aspekte von Performance-Vertr\u00e4gen bei der Zell- und Gentherapie","previousItem":{"@type":"ListItem","@id":"https:\/\/www.novacos-law.com\/de\/category\/events\/#listItem","name":"Events"}}]},{"@type":"Organization","@id":"https:\/\/www.novacos-law.com\/de\/#organization","name":"Novacos Law","description":"Heil \u2022 H\u00fcbner \u2022 Natz \u2022 Oeben Partnerschaft mbB","url":"https:\/\/www.novacos-law.com\/de\/"},{"@type":"Person","@id":"https:\/\/www.novacos-law.com\/de\/author\/irene\/#author","url":"https:\/\/www.novacos-law.com\/de\/author\/irene\/","name":"Irene Weigel","image":{"@type":"ImageObject","@id":"https:\/\/www.novacos-law.com\/de\/2021\/24-marburger-gespraeche-zum-pharmarecht-18-und-19-maerz-2021-rechtliche-aspekte-von-performance-vertraegen-bei-der-zell-und-gentherapie\/#authorImage","url":"https:\/\/secure.gravatar.com\/avatar\/4b6e23b267feeae9cffc7e4f81dbd2efa7e19c1035301edf6a24a7beb9ae5ac9?s=96&d=mm&r=g","width":96,"height":96,"caption":"Irene Weigel"}},{"@type":"WebPage","@id":"https:\/\/www.novacos-law.com\/de\/2021\/24-marburger-gespraeche-zum-pharmarecht-18-und-19-maerz-2021-rechtliche-aspekte-von-performance-vertraegen-bei-der-zell-und-gentherapie\/#webpage","url":"https:\/\/www.novacos-law.com\/de\/2021\/24-marburger-gespraeche-zum-pharmarecht-18-und-19-maerz-2021-rechtliche-aspekte-von-performance-vertraegen-bei-der-zell-und-gentherapie\/","name":"24. Marburger Gespr\u00e4che zum Pharmarecht (18. und 19. M\u00e4rz 2021) \u2013 Rechtliche Aspekte von Performance-Vertr\u00e4gen bei der Zell- und Gentherapie | NOVACOS","description":"Unser Partner Dr. Alexander Natz wird im Rahmen der 24. Marburger Gespr\u00e4che zum Pharmarecht am 18. M\u00e4rz 2021 online \u00fcber das Thema \u201eRechtliche Aspekte von Performance-Vertr\u00e4gen bei der Zell- und Gentherapie\u201c referieren. Weitere Informationen finden Sie hier.","inLanguage":"de-DE","isPartOf":{"@id":"https:\/\/www.novacos-law.com\/de\/#website"},"breadcrumb":{"@id":"https:\/\/www.novacos-law.com\/de\/2021\/24-marburger-gespraeche-zum-pharmarecht-18-und-19-maerz-2021-rechtliche-aspekte-von-performance-vertraegen-bei-der-zell-und-gentherapie\/#breadcrumblist"},"author":{"@id":"https:\/\/www.novacos-law.com\/de\/author\/irene\/#author"},"creator":{"@id":"https:\/\/www.novacos-law.com\/de\/author\/irene\/#author"},"datePublished":"2021-03-16T14:15:47+01:00","dateModified":"2021-03-16T14:40:55+01:00"},{"@type":"WebSite","@id":"https:\/\/www.novacos-law.com\/de\/#website","url":"https:\/\/www.novacos-law.com\/de\/","name":"Novacos Law","description":"Heil \u2022 H\u00fcbner \u2022 Natz \u2022 Oeben Partnerschaft mbB","inLanguage":"de-DE","publisher":{"@id":"https:\/\/www.novacos-law.com\/de\/#organization"}}]}},"aioseo_meta_data":{"post_id":"637","title":null,"description":null,"keywords":[],"keyphrases":{"focus":[],"additional":[]},"primary_term":null,"canonical_url":null,"og_title":null,"og_description":null,"og_object_type":"default","og_image_type":"default","og_image_url":null,"og_image_width":null,"og_image_height":null,"og_image_custom_url":null,"og_image_custom_fields":null,"og_video":"","og_custom_url":null,"og_article_section":null,"og_article_tags":[],"twitter_use_og":false,"twitter_card":"default","twitter_image_type":"default","twitter_image_url":null,"twitter_image_custom_url":null,"twitter_image_custom_fields":null,"twitter_title":null,"twitter_description":null,"schema":{"blockGraphs":[],"customGraphs":[],"default":{"data":{"Article":{"id":"aioseo-article-634d5ce594235","slug":"article","graphName":"Article","label":"Artikel","properties":{"type":"BlogPosting","name":"#post_title","headline":"#post_title","description":"#post_excerpt","image":"","keywords":"","author":{"name":"#author_name","url":"#author_url"},"dates":{"include":true,"datePublished":"","dateModified":""}}},"Course":[],"Dataset":[],"FAQPage":[],"Movie":[],"Person":[],"Product":[],"ProductReview":[],"Car":[],"Recipe":[],"Service":[],"SoftwareApplication":[],"WebPage":[]},"graphName":"Article","isEnabled":true},"graphs":[]},"schema_type":"default","schema_type_options":"{\"article\":{\"articleType\":\"BlogPosting\"},\"course\":{\"name\":\"\",\"description\":\"\",\"provider\":\"\"},\"faq\":{\"pages\":[]},\"product\":{\"reviews\":[]},\"recipe\":{\"ingredients\":[],\"instructions\":[],\"keywords\":[]},\"software\":{\"reviews\":[],\"operatingSystems\":[]},\"webPage\":{\"webPageType\":\"WebPage\"}}","pillar_content":false,"robots_default":true,"robots_noindex":false,"robots_noarchive":false,"robots_nosnippet":false,"robots_nofollow":false,"robots_noimageindex":false,"robots_noodp":false,"robots_notranslate":false,"robots_max_snippet":"-1","robots_max_videopreview":"-1","robots_max_imagepreview":"large","priority":null,"frequency":"default","location":null,"local_seo":{"businessInfo":{"name":"","urls":{"website":"","aboutPage":"","contactPage":""},"address":{"line1":"","line2":"","zip":"","city":"","state":"","country":""},"contact":{"email":"","phone":"","fax":""},"ids":{"vatID":"","taxID":"","chamberID":""},"payment":{"priceIndication":"","currenciesAccepted":"","methodsAccepted":""},"areaServed":""},"openingHours":{"show":false,"closedLabel":"","open24h":false,"open24hLabel":"","open247":false,"use24hFormat":false,"twoSets":false,"timezone":"","hours":[]}},"breadcrumb_settings":null,"limit_modified_date":false,"ai":null,"created":"2021-03-16 13:12:53","updated":"2025-07-25 09:14:03","seo_analyzer_scan_date":null},"aioseo_breadcrumb":"<div class=\"aioseo-breadcrumbs\"><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/www.novacos-law.com\/de\" title=\"Home\">Home<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">&raquo;<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/www.novacos-law.com\/de\/category\/events\/\" title=\"Events\">Events<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">&raquo;<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\t24. Marburger Gespr\u00e4che zum Pharmarecht (18. und 19. M\u00e4rz 2021) \u2013 Rechtliche Aspekte von Performance-Vertr\u00e4gen bei der Zell- und Gentherapie\n\t\t<\/span><\/div>","aioseo_breadcrumb_json":[{"label":"Home","link":"https:\/\/www.novacos-law.com\/de"},{"label":"Events","link":"https:\/\/www.novacos-law.com\/de\/category\/events\/"},{"label":"24. Marburger Gespr\u00e4che zum Pharmarecht (18. und 19. M\u00e4rz 2021) &#8211; Rechtliche Aspekte von Performance-Vertr\u00e4gen bei der Zell- und Gentherapie","link":"https:\/\/www.novacos-law.com\/de\/2021\/24-marburger-gespraeche-zum-pharmarecht-18-und-19-maerz-2021-rechtliche-aspekte-von-performance-vertraegen-bei-der-zell-und-gentherapie\/"}],"_links":{"self":[{"href":"https:\/\/www.novacos-law.com\/de\/wp-json\/wp\/v2\/posts\/637","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.novacos-law.com\/de\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.novacos-law.com\/de\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.novacos-law.com\/de\/wp-json\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/www.novacos-law.com\/de\/wp-json\/wp\/v2\/comments?post=637"}],"version-history":[{"count":0,"href":"https:\/\/www.novacos-law.com\/de\/wp-json\/wp\/v2\/posts\/637\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.novacos-law.com\/de\/wp-json\/wp\/v2\/media?parent=637"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.novacos-law.com\/de\/wp-json\/wp\/v2\/categories?post=637"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.novacos-law.com\/de\/wp-json\/wp\/v2\/tags?post=637"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}